1. 1384. RSV Monoclonal Antibody (MK-1654) Phase 1 Pharmacokinetics (PK) in Healthy Adults and Population PK Modeling to Support Pediatric Development. (26th November 2018) Authors: Maas, Brian; Aliprantis, Antonios; Wolford, Dennis; Fayad, Ghassan; Vora, Kalpit; Geng, Dong; Ma, Hua; Caro, Luzelena Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects. (26th November 2018) Authors: Aliprantis, Antonios; Wolford, Dennis; Caro, Luzelena; Maas, Brian; Ma, Hua; Vora, Kalpit; Geng, Dong; Railkar, Radha; Lee, Andrew; Sterling, Laura; Lai, Eseng Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study. Issue 10297 (24th July 2021) Authors: Berdeja, Jesus G; Madduri, Deepu; Usmani, Saad Z; Jakubowiak, Andrzej; Agha, Mounzer; Cohen, Adam D; Stewart, A Keith; Hari, Parameswaran; Htut, Myo; Lesokhin, Alexander; Deol, Abhinav; Munshi, Nikhil C; O'Donnell, Elizabeth; Avigan, David; Singh, Indrajeet; Zudaire, Enrique; Yeh, Tzu-Min; Allred... Journal: Lancet Issue: Volume 398:Issue 10297(2021) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗